{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:18:00Z","timestamp":1788455880912,"version":"build-2803163510"},"reference-count":57,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Conventional clinical and dermoscopic assessment may overestimate treatment response in locally advanced basal cell carcinoma (laBCC) treated with Hedgehog pathway inhibitors due to treatment-induced fibrosis, pigment retention, and stromal remodeling. Reflectance confocal microscopy (RCM) enables noninvasive, near-histologic resolution skin imaging and may improve response evaluation accuracy. This study evaluated the role of RCM in monitoring treatment response and guiding presurgical planning in laBCC patients treated with sonidegib. Methods: In this prospective, single-center, observational pilot study, 15 consecutive patients with laBCC unsuitable for upfront surgery received sonidegib 200 mg daily. Treatment response was assessed using integrated clinical examination and RCM at baseline and follow-up. Study-specific response categories (complete response [CR], partial response [PR], stable disease [SD], progressive disease [PD]) were adapted from RECIST principles. Presurgical RCM mapping was performed in partial responders. Interobserver agreement between two blinded RCM readers was assessed using Cohen\u2019s kappa (\u03ba). Results: The objective response rate was 93.3% (CR: 26.7%; PR: 66.7%; PD: 6.7%). Dose modifications were required in 73.3% of patients; adverse events occurred in 60.0%, most commonly dysgeusia (33.3%) and muscle cramps (20.0%). Clinical\u2013RCM discordance was identified in 13.3% of patients: lesions classified as CR by conventional evaluation were reclassified as PR after RCM detected persistent basaloid tumor nests, prompting treatment continuation (Interobserver agreement: \u03ba = 0.62\u20130.86). Conclusions: RCM identified residual disease missed by conventional assessment, directly influencing treatment decisions. These findings support integrating RCM into a multimodal, response-adapted management strategy for laBCC. However, the limited sample size warrants cautious interpretation, and larger multicenter studies are required before broad clinical implementation.<\/jats:p>","DOI":"10.3390\/cancers18172858","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:21:21Z","timestamp":1788452481000},"page":"2858","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reflectance Confocal Microscopy for Treatment Response Monitoring in Locally Advanced Basal Cell Carcinoma Treated with Sonidegib: A Prospective Observational Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-4172","authenticated-orcid":false,"given":"Federico","family":"Venturi","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Carlotta","family":"Baraldi","sequence":"additional","affiliation":[{"name":"Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6555-6227","authenticated-orcid":false,"given":"Barbara","family":"Corti","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1041-391X","authenticated-orcid":false,"given":"Barbara","family":"Melotti","sequence":"additional","affiliation":[{"name":"Oncology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3263-4353","authenticated-orcid":false,"given":"Elisabetta","family":"Magnaterra","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Biagio","family":"Scotti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2861","authenticated-orcid":false,"given":"Emi","family":"Dika","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2022.03.023","article-title":"Advanced basal cell carcinoma: What dermatologists need to know about diagnosis","volume":"86","author":"Krakowski","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2025.18749","article-title":"Keratinocyte Carcinoma: A Review","volume":"335","author":"Wehner","year":"2026","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e71448","DOI":"10.1002\/cam4.71448","article-title":"Comprehensive Insights Into Basal Cell Carcinoma: Causes, Presentation, Prevention, and Modern Therapeutic Approaches","volume":"14","author":"Levit","year":"2025","journal-title":"Cancer Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","article-title":"Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines","volume":"118","author":"Peris","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2022.4590","article-title":"Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice Guidelines","volume":"159","author":"Mirali","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Bichakjian","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CCO.0b013e32835ff438","article-title":"Advanced basal cell carcinoma of the skin: Targeting the hedgehog pathway","volume":"25","author":"Sekulic","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13671-014-0069-y","article-title":"Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations","volume":"3","author":"Mohan","year":"2014","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1878-0261.12412","article-title":"Interplay between small and long non-coding RNAs in cutaneous melanoma: A complex jigsaw puzzle with missing pieces","volume":"13","author":"Riefolo","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jid.2020.03.949","article-title":"Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma","volume":"140","author":"Dika","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41419-021-03764-y","article-title":"Unraveling the role of microRNA\/isomiR network in multiple primary melanoma pathogenesis","volume":"12","author":"Dika","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14737159.2022.2049243","article-title":"Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer","volume":"22","author":"Durante","year":"2022","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Naddeo, M., Broseghini, E., Venturi, F., Vaccari, S., Corti, B., Lambertini, M., Ricci, C., Fontana, B., Durante, G., and Pariali, M. (2024). Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas. Cancers, 16.","DOI":"10.3390\/cancers16091688"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/annonc\/mdv551","article-title":"Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: An integrative molecular and surgical case study","volume":"27","author":"Sand","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cosio, T., Di Prete, M., Di Raimondo, C., Garofalo, V., Lozzi, F., Lanna, C., Dika, E., Orlandi, A., Rapanotti, M.C., and Bianchi, L. (2021). Patidegib in Dermatology: A Current Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910725"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40257-026-01037-y","article-title":"Transforming Outcomes in Advanced Basal Cell Carcinoma: The Evolving Role of Systemic Therapy","volume":"27","author":"Verkouteren","year":"2026","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/1061186X.2025.2496470","article-title":"Hedgehog signalling pathway inhibitors in the treatment of basal cell carcinoma: An updated review","volume":"33","author":"Glibo","year":"2025","journal-title":"J. Drug Target."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113254","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023","volume":"192","author":"Peris","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"De Giorgi, V., Scarf\u00ec, F., Trane, L., Silvestri, F., Venturi, F., Zuccaro, B., Spinelli, G., Scoccianti, S., De Rosa, F., and Dika, E. (2021). Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting. Cancers, 13.","DOI":"10.3390\/cancers13225706"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bjd.18552","article-title":"Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study","volume":"182","author":"Dummer","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_21","first-page":"e32","article-title":"Cytoreductive approach with hedgehog inhibitors followed by reflectance confocal microscopy assisted Mohs surgery for morpheiform basal cell carcinoma","volume":"39","author":"Venturi","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/jdv.16230","article-title":"Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: A joint expert opinion","volume":"34","author":"Dummer","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1002\/ski2.260","article-title":"Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)","volume":"3","author":"Venturi","year":"2023","journal-title":"Skin. Health Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e15191","DOI":"10.1111\/dth.15191","article-title":"The clinical impact of hedgehog pathway inhibitors and statin therapy in the treatment of locally advanced basal cell carcinoma: A case report","volume":"35","author":"Trane","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"adv00740","DOI":"10.2340\/actadv.v102.1995","article-title":"Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study","volume":"102","author":"Herms","year":"2022","journal-title":"Acta Derm. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/ced.14804","article-title":"Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma","volume":"46","author":"Trane","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ced\/llaf383","article-title":"Management of advanced basal cell carcinoma with hedgehog inhibitors: A real-world prospective comparative study","volume":"51","author":"Venturi","year":"2026","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1634\/theoncologist.2018-0924","article-title":"A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors","volume":"24","author":"Dessinioti","year":"2019","journal-title":"Oncologist"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaad.2014.04.007","article-title":"Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: Pseudocysts as a sign of tumor regression","volume":"71","author":"Maier","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/jdv.14650","article-title":"Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment","volume":"32","author":"Couzan","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e15832","DOI":"10.1111\/dth.15832","article-title":"Noninvasive diagnostic techniques in the preoperative setting of Mohs micrographic surgery: A review of the literature","volume":"35","author":"Venturi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fournier, L., de Geus-Oei, L.-F., Regge, D., Oprea-Lager, D.-E., D\u2019Anastasi, M., Bidaut, L., B\u00e4uerle, T., Lopci, E., Cappello, G., and Lecouvet, F. (2021). Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group\u2014ESOI Joint Paper. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.800547"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gutzmer, R., Robert, C., Loquai, C., Schadendorf, D., Squittieri, N., Arntz, R., Martelli, S., and Dummer, R. (2021). Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: Results from a preplanned sensitivity analysis. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08968-1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jdv.14542","article-title":"Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study","volume":"32","author":"Lear","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/exd.14882","article-title":"Neoadjuvant treatment of basosquamous carcinomas with Sonidegib: An innovative approach","volume":"32","author":"Dika","year":"2023","journal-title":"Exp. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.det.2016.06.001","article-title":"The Role of Reflectance Confocal Microscopy in Clinical Trials for Tumor Monitoring","volume":"34","author":"Guilera","year":"2016","journal-title":"Dermatol. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamadermatol.2018.2446","article-title":"Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma","volume":"154","author":"Sahu","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2019.02.049","article-title":"Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study","volume":"81","author":"Cordova","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e949669","DOI":"10.12659\/MSM.949669","article-title":"Non-Invasive Imaging in Post-Radiotherapy Monitoring of Non-Melanoma Skin Cancer","volume":"31","author":"Sobolewski","year":"2025","journal-title":"Med. Sci. Monit."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104235","DOI":"10.1016\/j.pdpdt.2024.104235","article-title":"Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis","volume":"48","author":"Venturi","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3422734","DOI":"10.1155\/dth\/3422734","article-title":"Prospective Observational Study on the Use of Confocal Microscopy in Defining Pre-Operative Surgical Margins of Non Melanoma Skin Cancers of the Head and Neck Treated With Mohs Surgery","volume":"2025","author":"Venturi","year":"2025","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Venturi, F., Magnaterra, E., Scotti, B., Baraldi, C., and Dika, E. (2025). How We Do It: Presurgical Tumor Mapping With Confocal Microscopy in Mohs Surgery Using Skin Adhesive Suture Tapes. Dermatol. Surg., epub ahead of print.","DOI":"10.1097\/DSS.0000000000004958"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2020.05.153","article-title":"Reflectance confocal microscopy: Principles, basic terminology, clinical indications, limitations, and practical considerations","volume":"84","author":"Shahriari","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","first-page":"CD013191","article-title":"Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105359","DOI":"10.1016\/j.pdpdt.2026.105359","article-title":"Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses","volume":"58","author":"Venturi","year":"2026","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2025.11.037","article-title":"Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study","volume":"94","author":"Gioacchini","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/jdv.15091","article-title":"Reflectance confocal microscopy: A crucial role for actinic keratosis treatment monitoring","volume":"32","author":"Pellacani","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ced\/llaf407","article-title":"Reflectance confocal microscopy for monitoring treatment response in superficial basal cell carcinoma: Diagnostic challenges due to scar formation","volume":"51","author":"Clark","year":"2026","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ijd.70103","article-title":"Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus","volume":"65","author":"Ascierto","year":"2025","journal-title":"Int. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1159\/000531280","article-title":"Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness","volume":"239","author":"Mannino","year":"2023","journal-title":"Dermatology"},{"key":"ref_51","first-page":"e14057","article-title":"Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving","volume":"33","author":"Mazzeo","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wojtowicz, I., and \u017bychowska, M. (2025). Dermoscopy of Basal Cell Carcinoma Part 1: Dermoscopic Findings and Diagnostic Accuracy-A Systematic Literature Review. Cancers, 17.","DOI":"10.3390\/cancers17030493"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1111\/jdv.19608","article-title":"Analysis of basal cell carcinomas\u2019 histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin-Goltz syndrome: A retrospective study","volume":"38","author":"Scotti","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_54","first-page":"453","article-title":"Efficacy, tolerability, and quality of life evaluation in six patients affected by Gorlin-Goltz syndrome and treated with vismodegib 150 mg\/die: A retrospective monocentric cohort analysis","volume":"159","author":"Scotti","year":"2024","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_55","first-page":"0202a08","article-title":"Extensive regression in pigmented skin lesions: A dangerous confounding feature","volume":"2","author":"Lallas","year":"2012","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/jdv.19806","article-title":"Dynamic optical coherence tomography evaluation in locally advanced basal cell carcinoma during sonidegib treatment","volume":"38","author":"Cantisani","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/jdv.14771","article-title":"Interrater and intrarater agreement of confocal microscopy imaging in diagnosing and subtyping basal cell carcinoma","volume":"32","author":"Kadouch","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2858\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:27:53Z","timestamp":1788452873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":57,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172858"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172858","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}